Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized, Double Blind, Placebo Controlled Trial Of Carboplatin/Etoposide With Or Without Thalidomide In Small Cell Lung Cancer (Study 12)

NCT00061919 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00061919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00061919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized, Double Blind, Placebo Controlled Trial Of Carboplatin/Etoposide With Or Without Thalidomide In Small Cell Lung Cancer (Study 12)
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2003
Completion date
July 31, 2007
Enrollment
724 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer